PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'CAAT-Europe at the University of Konstanz, 78457, Konstanz, Germany.\', \'ALTERTOX, 1000, Brussels, Belgium.\', \'CAAT, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, 21287, USA.\', \'CAAT-Europe at the University of Konstanz, 78457, Konstanz, Germany. marcel.leist@uni-konstanz.de.\', \'In Vitro Toxicology and Biomedicine, Department Inaugurated By the Doerenkamp-Zbinden Foundation, University of Konstanz, 78457, Konstanz, Germany. marcel.leist@uni-konstanz.de.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s00204-020-02787-2
?:doi
?:hasPublicationType
?:journal
  • Archives of toxicology
is ?:pmid of
?:pmid
?:pmid
  • 32447523
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.541
?:rankingScore_hIndex
  • 90
is ?:relation_isRelatedTo_publication of
?:title
  • Harnessing the power of novel animal-free test methods for the development of COVID-19 drugs and vaccines.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all